Related Experiment Video
Updated: Sep 3, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
[Fecal incontinence - symptoms are guiding therapy]
Fecal incontinence (FI) is a growing health issue, particularly in older adults. Management involves lifestyle changes, physiotherapy, and medication, with sacral neuromodulation offering a successful invasive option.
Area of Science:
- Gastroenterology
- Geriatrics
- Urology
Background:
- Fecal incontinence (FI) is a significant and increasing medical concern, particularly affecting the geriatric population due to rising life expectancy.
- Prevalence estimates range from 4% in adults to over 50% in octogenarians, with underreporting likely leading to underestimation.
Purpose of the Study:
- To review the current understanding of fecal incontinence, including its prevalence, diagnosis, and management strategies.
- To highlight the multifactorial nature of FI and the importance of patient compliance in therapeutic approaches.
Main Methods:
- Diagnosis relies primarily on patient history and caregiver information, with technical procedures being secondary.
- Review of established and emerging therapeutic interventions for fecal incontinence.
Main Results:
- FI is often multifactorial, involving progressive loss of anorectal continence.
- Conservative treatments include lifestyle modifications, physiotherapy, and medical therapy, with varying patient compliance.
- Sacral neuromodulation has emerged as a successful invasive treatment, and in some cases, a permanent stoma can improve quality of life.
Conclusions:
- Effective management of fecal incontinence requires a comprehensive approach tailored to the individual patient.
- While conservative measures are the mainstay, advanced interventions like sacral neuromodulation and surgical options like stoma creation offer solutions for refractory cases.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

